DE69800753T4 - Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virus - Google Patents
Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virusInfo
- Publication number
- DE69800753T4 DE69800753T4 DE69800753T DE69800753T DE69800753T4 DE 69800753 T4 DE69800753 T4 DE 69800753T4 DE 69800753 T DE69800753 T DE 69800753T DE 69800753 T DE69800753 T DE 69800753T DE 69800753 T4 DE69800753 T4 DE 69800753T4
- Authority
- DE
- Germany
- Prior art keywords
- reverstranscriptase
- retroviral
- hepatitis
- virus
- dna polymerase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702957A SE9702957D0 (sv) | 1997-08-15 | 1997-08-15 | Antivirals |
SE9704147A SE9704147D0 (sv) | 1997-11-12 | 1997-11-12 | Nucleosides |
SE9800452A SE9800452D0 (sv) | 1998-02-13 | 1998-02-13 | Antivirals |
PCT/SE1998/001467 WO1999009031A1 (en) | 1997-08-15 | 1998-08-14 | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69800753T2 DE69800753T2 (de) | 2001-10-25 |
DE69800753T4 true DE69800753T4 (de) | 2002-02-21 |
Family
ID=27355886
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69829784T Expired - Lifetime DE69829784T2 (de) | 1997-08-15 | 1998-08-14 | 3'-Fluorierte Guanosinderivate zur Behandlung oder Prophylaxe von HBV- oder retroviralen Infektionen |
DE69800753T Expired - Lifetime DE69800753T4 (de) | 1997-08-15 | 1998-08-14 | Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virus |
DE69800753A Expired - Lifetime DE69800753D1 (de) | 1997-08-15 | 1998-08-14 | Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virus |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69829784T Expired - Lifetime DE69829784T2 (de) | 1997-08-15 | 1998-08-14 | 3'-Fluorierte Guanosinderivate zur Behandlung oder Prophylaxe von HBV- oder retroviralen Infektionen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69800753A Expired - Lifetime DE69800753D1 (de) | 1997-08-15 | 1998-08-14 | Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virus |
Country Status (24)
Country | Link |
---|---|
EP (2) | EP0988304B1 (de) |
JP (1) | JP3844654B2 (de) |
KR (1) | KR100529272B1 (de) |
CN (2) | CN1286845C (de) |
AT (2) | ATE200900T1 (de) |
AU (1) | AU728892B2 (de) |
CA (1) | CA2298704C (de) |
CZ (1) | CZ300757B6 (de) |
DE (3) | DE69829784T2 (de) |
DK (1) | DK0988304T3 (de) |
ES (2) | ES2158689T3 (de) |
GR (1) | GR3036004T3 (de) |
HK (2) | HK1032968A1 (de) |
HU (1) | HU228060B1 (de) |
IL (2) | IL134503A0 (de) |
MY (1) | MY116269A (de) |
NZ (1) | NZ502837A (de) |
PL (1) | PL338643A1 (de) |
PT (1) | PT988304E (de) |
SG (1) | SG96604A1 (de) |
SI (1) | SI0988304T1 (de) |
TR (2) | TR200000398T2 (de) |
TW (1) | TW580500B (de) |
WO (1) | WO1999009031A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458772B1 (en) * | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
FR2794752A1 (fr) * | 1999-06-11 | 2000-12-15 | Laphal Sa Lab | Nouveaux composes derives de nucleosides, leurs procedes de preparation, et les compositions pharmaceutiques en renfermant |
FR2796384A1 (fr) * | 1999-07-12 | 2001-01-19 | Laphal Sa Lab | Nouveaux esters derives de nucleosides, leurs procedes de preparation et les compositions pharmaceutiques en renfermant |
MY141789A (en) | 2001-01-19 | 2010-06-30 | Lg Chem Investment Ltd | Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same. |
AUPS037002A0 (en) * | 2002-02-07 | 2002-02-28 | Melbourne Health | Viral variants and uses therefor |
EP1610781A1 (de) * | 2003-03-27 | 2006-01-04 | Boehringer Ingelheim International GmbH | Antivirale kombination von tipranavir und einer weiteren antiretroviralen verbindung |
WO2004087169A1 (en) * | 2003-03-27 | 2004-10-14 | Boehringer Ingelheim International Gmbh | Antiviral combination of nevirapine and a further antiretroviral compound |
WO2004087140A1 (en) * | 2003-03-27 | 2004-10-14 | Boehringer Ingelheim International Gmbh | Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound |
GB0400290D0 (en) | 2004-01-08 | 2004-02-11 | Medivir Ab | dUTPase inhibitors |
GB0513835D0 (en) | 2005-07-07 | 2005-08-10 | Medivir Ab | HIV inhibitors |
KR20140007443A (ko) * | 2011-02-21 | 2014-01-17 | 메디비르 아베 | Flg의 합성 |
CA2999367C (en) * | 2015-09-23 | 2023-09-26 | Xw Laboratories Inc. | Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof |
CN114901657A (zh) * | 2019-10-17 | 2022-08-12 | 人工智能生物制药公司 | 抗病毒和肝靶向药物 |
CN114686188B (zh) * | 2020-12-31 | 2023-05-02 | 中石化石油工程技术服务有限公司 | 一种核苷磷脂钻井液润滑剂及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8602981D0 (sv) * | 1986-07-04 | 1986-07-04 | Astra Laekemedel Ab | Novel medicinal use |
GB8719367D0 (en) * | 1987-08-15 | 1987-09-23 | Wellcome Found | Therapeutic compounds |
ATE93236T1 (de) * | 1987-10-28 | 1993-09-15 | Pro Neuron Inc | Acylatiertes uridin und cytidin und deren verwendungen. |
EP0375329B1 (de) * | 1988-12-19 | 1995-05-31 | The Wellcome Foundation Limited | Antivirale Pyrimidin- und Purinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate |
IL100874A (en) * | 1991-02-08 | 1996-01-19 | Pro Neuron Inc | Oxiforin nucleosides and their composition, for use as medicines, their preparation and pharmaceutical preparations containing them |
DE4311801A1 (de) * | 1993-04-09 | 1994-10-13 | Hoechst Ag | Neue Carbonsäureester von 2-Amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren Herstellung sowie deren Verwendung |
PE32296A1 (es) * | 1994-07-28 | 1996-08-07 | Hoffmann La Roche | Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables |
AU1592897A (en) * | 1996-01-26 | 1997-08-20 | F. Hoffmann-La Roche Ag | Process for preparing purine derivatives |
US5869493A (en) * | 1996-02-16 | 1999-02-09 | Medivir Ab | Acyclic nucleoside derivatives |
AU735438B2 (en) * | 1996-11-12 | 2001-07-05 | Medivir Ab | Nucleosides |
-
1998
- 1998-08-14 DE DE69829784T patent/DE69829784T2/de not_active Expired - Lifetime
- 1998-08-14 ES ES98939041T patent/ES2158689T3/es not_active Expired - Lifetime
- 1998-08-14 ES ES01103370T patent/ES2239637T3/es not_active Expired - Lifetime
- 1998-08-14 DE DE69800753T patent/DE69800753T4/de not_active Expired - Lifetime
- 1998-08-14 PL PL98338643A patent/PL338643A1/xx unknown
- 1998-08-14 DK DK98939041T patent/DK0988304T3/da active
- 1998-08-14 CN CNB031579884A patent/CN1286845C/zh not_active Expired - Fee Related
- 1998-08-14 AT AT98939041T patent/ATE200900T1/de active
- 1998-08-14 CA CA002298704A patent/CA2298704C/en not_active Expired - Lifetime
- 1998-08-14 EP EP98939041A patent/EP0988304B1/de not_active Expired - Lifetime
- 1998-08-14 NZ NZ502837A patent/NZ502837A/xx not_active IP Right Cessation
- 1998-08-14 CZ CZ20000449A patent/CZ300757B6/cs not_active IP Right Cessation
- 1998-08-14 SG SG200101048A patent/SG96604A1/en unknown
- 1998-08-14 KR KR10-2000-7001476A patent/KR100529272B1/ko not_active IP Right Cessation
- 1998-08-14 TR TR2000/00398T patent/TR200000398T2/xx unknown
- 1998-08-14 IL IL13450398A patent/IL134503A0/xx unknown
- 1998-08-14 HU HU0100087A patent/HU228060B1/hu not_active IP Right Cessation
- 1998-08-14 JP JP2000509711A patent/JP3844654B2/ja not_active Expired - Fee Related
- 1998-08-14 AT AT01103370T patent/ATE293112T1/de not_active IP Right Cessation
- 1998-08-14 DE DE69800753A patent/DE69800753D1/de not_active Expired - Lifetime
- 1998-08-14 CN CN98810219A patent/CN1130362C/zh not_active Expired - Fee Related
- 1998-08-14 TW TW087113427A patent/TW580500B/zh not_active IP Right Cessation
- 1998-08-14 EP EP01103370A patent/EP1123935B1/de not_active Expired - Lifetime
- 1998-08-14 AU AU87548/98A patent/AU728892B2/en not_active Ceased
- 1998-08-14 PT PT98939041T patent/PT988304E/pt unknown
- 1998-08-14 MY MYPI98003706A patent/MY116269A/en unknown
- 1998-08-14 TR TR2000/02273T patent/TR200002273T2/xx unknown
- 1998-08-14 WO PCT/SE1998/001467 patent/WO1999009031A1/en active IP Right Grant
- 1998-08-14 SI SI9830031T patent/SI0988304T1/xx unknown
-
2000
- 2000-02-10 IL IL134503A patent/IL134503A/en not_active IP Right Cessation
-
2001
- 2001-05-23 HK HK01103586A patent/HK1032968A1/xx not_active IP Right Cessation
- 2001-06-06 GR GR20010400857T patent/GR3036004T3/el unknown
-
2007
- 2007-03-27 HK HK07103270.8A patent/HK1097550A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1097550A1 (en) | Antiviral nucleoside analogues as inhibitors of retroviral reverse transcriptase and dna polymerase | |
DE69801802T2 (de) | Substituierte propargylethoxyamido-nukleoside | |
DK0663922T3 (da) | Nukleotider mærket med infrarødt farvestof og deres anvendelse til nukleinsyredetektion | |
TR200100438T2 (tr) | Hepatit C inhibitörü peptitler | |
DE60325692D1 (de) | Pyrimidinonen als virale polymerase inhibitoren | |
MEP58508A (en) | Hepatitis c inhibitor tri-peptides | |
DK0777679T3 (da) | Indføring af nukleinsyrer | |
ATE416186T1 (de) | Phenylethylenamin-derivate | |
DK0489836T3 (da) | Lysaktiverede acyl-enzymer | |
NO20084343L (no) | Fremgangsmate for fremstilling av 6-(4-fenylbutoksy)heksylaminderivater | |
BG102647A (en) | Acyclic nucleoside derivatives | |
DK0497121T3 (da) | Hidtil ukendte tetrazolderivater, fremgangsmåde til fremstilling af disse og anvendelsen af disse | |
ES2164869T3 (es) | Conjugados lipidos especificos de nucleosidos-difosfato y su uso como medicamentos. | |
EA200100711A1 (ru) | Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция | |
DK1205476T3 (da) | Fremgangsmåde til syntese af N-(mercaptoacyl)-aminosyrederivater ud fra alfa-substituerede acrylsyrer | |
BR9807312A (pt) | Derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos | |
ES2186127T3 (es) | Sintesis de derivados de nucleosidos aciclicos. | |
ES2098084T3 (es) | Procedimiento para la acilacion de derivados de treonina y su uso para la preparacion de 1,4-dihidropiridinas. | |
RU2002102009A (ru) | Оптически активные амиды 1-(4-хлорбензоил)-5-метокси-2-метилиндол-3-уксусной кислоты с производными (S)-аминокислот |